GENOMTEC IN TOP 5 OF INCREDIBLES ACCELERATOR

We are pleased to inform you that our portfolio company Genomtec was among the five startups qualified for the finals of the second edition of the InCredibles accelerator, founded by Sebastian Kulczyk.

In this year’s event the organizers looked for companies that have a prototype of a new product or service, a proven team and are ready for international expansion.
The finalists of the competition will receive non-returnable grants of USD 50,000 and go through a mentoring program adapted to their needs. The winning teams will soon spend six weeks in the Silicon Valley, where they will meet, among others, with experts from Singularity University.

Over 300 teams from 34 countries have applied for participation in the second edition of InCredibles. These were startups mainly from Central and Eastern Europe, operating in the software, healthtech and fintech sectors.

Congratulations to the Genomtec team!
More information at MamStartup.pl.

PREGNABIT AWARDED AT PITCHFIRE COMPETITION 2018 IN DENMAR

Nestmedic’s telemedical CTG Pregnabit was awarded at the “Pitchfire Competition”, organized during the “Week of Health and Innovation” trade fair held on October 9-11 in Odense, Denmark.

The jury of the competition, after listening to many presentations of medical startups, rewarded the Nestmedic team for the Pregnabit telemedical CTG solution. Pregnabit is the world’s first comprehensive telemedicine solution for studying fetal well-being. The main element of the solution is a portable measuring device that allows for safe and reliable examination of the fetal heart rate, the mother’s pulse and the record of the uterine muscle contraction. The data collected by the device is transmitted wirelessly to the Medical Telemonitoring Center, operated by qualified medical personnel.

The Pitchfire Competition jury consisted of representatives of Venture Capital foundations, CONNECT Denmark, The Danish Growth Fund, regional and international business angels, and invited private investors. The prize in the competition is a dedicated business session with the best advisors in Denmark, gathered in the CONNECT Denmark organization.

Congratulations!

GENOMTEC WINS AT HUBWEEK IN BOSTON

Genomtec’s collection of awards is expanding. A few days ago, the company won the first place in the competition for the best startup from outside the US, organized during HUBweek in Boston.
This is one of the largest events in the technology industry on the East Coast of the United States, in which over 50,000 people representing dozens of industries and countries take part.

The Genomtec team had the opportunity to present their solution during HUBweek as a laureate of the 4th edition of MIT Enterprise Forum Poland – one of the largest acceleration programs for technological startups in Poland.

Genomtec has developed a portable device that allows diagnostics, among others of bacterial and viral infections, fungal infections or genetic mutations in any place within just 20 minutes, without having to prepare a sample of biological material. The Genomtec team also developed a device dedicated to the fruit and vegetable market. “Genomtec Fresh” analyzes the microbiological composition of soil, plants and water. It enables fast and cheap diagnostics of viruses and bacteria, and thus contributes to the increase of harvest and allows to minimize the use of chemicals.

Congratulations to the entire Genomtec team!

QUARTICON POTENTIAL RECOGNIZED BY A FOREIGN INVESTOR

QuarticON, our portfolio company, which created the systems of support and personalization of sales processes and Internet marketing based on artificial intelligence, raised PLN 8 million from the German Acatis Investment fund.

“We have seen that QuarticOn is well on its way to effectively use technology based on artificial intelligence to support sales in online stores, improving their competitiveness. The company has been steadily increasing its revenues and customer base, so it was natural for us to financially support its further development” – said Dr. Hendrik Leber, Managing Partner at Acatis Investment GmbH.

The funds obtained from Acatic Investment will be used by the Company for expansion into new markets and completion of work on a solution in the SaaS model.
QuarticON wants to debut on New Connect stock exchange in October.
We keep our fingers crossed for a successful debut!

More information in Puls Biznesu.

INNOVATIONS IN THE FINTECH INDUSTRY. MEET FUNEDA – OUR NEXT INVESTMENT

Funeda is an innovative company from the consumer financial services sector. The company develops an advanced creditworthiness and fraud risk assessment engine based on the Big Data methods and self-learning algorithms. The technology based on machine learning makes algorithms evolve and calibrate parameters in real time. The unique feature of the engine is the possibility of its application in various markets. Funeda started operations on the Polish FinTech market in April this year, while in Q42018 it plans to start operations on the first foreign market, with a potential much higher than the Polish market.

Leonarto Alfa investment is co-financed by the European Union from the European Regional Development Fund under the Operational Program Smart Development, Sub-measure 1.3.1. Support for research and development projects in the preseed phase by proof of concept funds – BRIdge Alfa.

PULS BIZNESU ABOUT COOPERATION BETWEEN EMPLOCITY AND AVIVA

We encourage you to read the article in the Puls Biznesu daily about the next implementation project of our portfolio company – Emplocity. This time, the company started cooperation with Aviva.

The solution developed by Emplocity – Emplobot – was already recognized by the largest Polish employers, such as: Budimex, mBank, Enprom or Santander Bank.

– In the last few months we have noticed a significant increase of interest in Emplobot. We are extremely pleased that Polish companies are open to new recruitment technologies – says Krzysztof Sobczak, CEO of Emplocity.

Congratulations! We are looking forward to next implementations with business partners.

OUR NEXT INVESTMENT IN THE LIFE SCIENCE AREA: BIOTTS SA

BIOTTS SA – Wroclaw biotechnology startup – creates proprietary medicinal preparations dedicated among others to areas of medicine such as oncology, immunology or neurology.
As part of the Leonarto Alfa investment, the Company will develop innovative carriers of therapeutic substances with the possibility of application in transdermal therapeutic systems, patches, ointments, gels. The carriers contain mixtures of substances compatible with human skin coatings, non-sensitizing, non-irritant, and most importantly, increasing the absorption of medicinal substances.
We keep our fingers crossed for the team headed by the founders of the company – Dr. Jan Meler and Dr. Paweł Biernat.

Leonarto Alfa investment is co-financed by the European Union from the European Regional Development Fund under the Operational Program Smart Development, Sub-measure 1.3.1. Support for research and development projects in the preseed phase by proof of concept funds – BRIdge Alfa.

Contact us